You are here: Industry Insights > COVID-19

News List

CHMP recommends use of Pfizer-BioNTech’s Covid-19 vaccine in children Pharmaceutical-Business-Review
November 29, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, in children aged five to 11 years.
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial Pharmaceutical-Technology
November 29, 2021
Clover Biopharmaceuticals has begun a Phase II clinical trial to assess its Covid-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), as a heterologous booster shot in people who received an initial vaccine regimen.
Zydus Cadila likely to launch Covid-19 vaccine ZyCoV-D next month Ref: Business Standard FirstWordPharma
November 26, 2021
India's fourth COVID-19 vaccine is likely to be available next month as sources say Cadila Healthcare's ZyCoV-D, the world’s first plasmid DNA vaccine, will be launched in December, reported Business Standard.
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age Drugs
November 26, 2021
Pfizer Inc. and BioNTech SE today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age...
Chinese mainland reports two locally transmitted COVID-19 cases NMPA
November 26, 2021
The Chinese mainland on Nov 24 reported two new locally transmitted COVID-19 cases, both of which were reported in Yunnan province, the National Health Commission said in its daily report on Nov 25.
Gout Drug Colchicine Won't Help Fight COVID-19 Drugs
November 26, 2021
Add an inexpensive gout drug to the growing list of medications touted as potential COVID-19 treatments -- only to offer no apparent benefit.
COVID Protection Wanes After 2 Doses of Pfizer Vaccine: Study Drugs
November 26, 2021
Protection can gradually fade after a second dose of the COVID-19 vaccine by Pfizer-BioNTech, which suggests that a booster shot might be necessary, researchers report.
EMA receive marketing authorisation application for molnupiravir PharmaTimes
November 26, 2021
The use of molnupiravir in COVID-19 cases aims to reduce the pressure on hospitals, in turn reducing the risk of patients developing more severe symptoms of the virus.
Health Canada approves Johnson & Johnson’s single-dose Covid-19 vaccine Pharmaceutical-Business-Review
November 26, 2021
Health Canada has granted full approval to Janssen Pharmaceutical Companies of Johnson & Johnson’s single-dose Covid-19 vaccine for the disease prevention in people aged 18 years and above.
AZD7442 reduces COVID-19 risks by 83 percent in Phase III trial EuropeanPharmaceuticalReview
November 26, 2021
AstraZeneca has announced new data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials which both showed robust efficacy from a one-time intramuscular...